Detalles de la búsqueda
1.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335916
2.
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.
Haematologica
; 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38058184
3.
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis.
Ann Hematol
; 102(4): 761-768, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36773040
4.
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Ann Hematol
; 102(5): 1099-1109, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959485
5.
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy.
Eur J Haematol
; 110(6): 696-705, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919878
6.
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.
Am J Hematol
; 98(11): 1762-1771, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647134
7.
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges.
Curr Treat Options Oncol
; 24(6): 693-710, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099265
8.
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study.
Ann Hematol
; 101(4): 855-867, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35128571
9.
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature.
Acta Haematol
; 145(5): 566-570, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580565
10.
Germline DDX41 mutations define a significant entity within adult MDS/AML patients.
Blood
; 134(17): 1441-1444, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31484648
11.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica
; 106(6): 1559-1568, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32467145
12.
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Ann Hematol
; 100(7): 1837-1847, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33948721
13.
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
Eur J Haematol
; 105(3): 286-291, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32365249
14.
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
Am J Hematol
; 95(12): 1466-1472, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32777149
15.
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Haematologica
; 104(8): 1589-1596, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819917
16.
New Treatment Options for Acute Myeloid Leukemia in 2019.
Curr Oncol Rep
; 21(2): 16, 2019 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30715623
17.
Life-threatening complications and intensive care unit management in patients treated with blinatumomab for B-cell acute lymphoblastic leukemia.
Crit Care
; 28(1): 14, 2024 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183144
18.
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib.
Br J Haematol
; 182(5): 701-704, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984826
19.
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Br J Haematol
; 203(4): e98-e101, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533098
20.
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Haematologica
; 107(4): 996-999, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35021604